Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review
<p dir="ltr">Fibrolamellar hepatocellular carcinoma is a rare type of hepatocellular carcinoma with unclear etiology. Its prevalence ranges from 0.6%-5%. One of the rare manifestations of FHCC includes hyperammonemic hepatic encephalopathy (HAE). Data regarding HAE in FHCC is limited...
Saved in:
| Main Author: | Arwa Ahmed (17563305) (author) |
|---|---|
| Other Authors: | Fateen Ata (12217764) (author), Mohammed Gaber (14151942) (author), Mahir Petkar (11569673) (author), Ahmed Mahfouz (737928) (author), Peter Schirmacher (173749) (author), Sara Musa (14152662) (author), Ahmed Hashim (597298) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A possible culprit for refractory angina
by: Nature Research (16552612)
Published: (2015) -
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma
by: Qiongzhu Dong (5156150)
Published: (2019) -
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
by: Nabil E. Omar (9545756)
Published: (2025) -
Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report
by: Abdulrahman F. Al-Mashdali (17148316)
Published: (2021) -
Wernicke encephalopathy after sleeve gastrectomy
by: Abdulrahman F. Al-Mashdali (17148316)
Published: (2022)